Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29

open access

Page views 566
Article views/downloads 3617
Get Citation

Connect on Social Media

Connect on Social Media

Antiangiogenic treatment in patients with renal cell carcinoma

Jakub Żołnierek, Cezary Szczylik

Abstract

Due to its increasing incidence, stilth course and resistance to classic pharmacotherapy, renal cell carcinoma (RCC) is a specific and important clinical problem. Advanced laboratory techniques helped to identify the potent role of membrane receptors for growth factors and cascade of triggered molecular reactions that lead to phenotypic changes from normal to neoplastic, uncontrolled proliferation and angiogenesis. Due to its high metabolic activity, formation of new blood vessels within the tumor burden is crucial for the development of renal cell carcinoma. Main points for signals transduction in angiogenesis are VEGF-dependent and PDGF- -dependent pathways. Agents targeting certain elements of these chain reactions linking cell membrane and the nucleus are effective in therapy of patients with metastatic renal cell carcinoma.

Article available in PDF format

View PDF (Polish) Download PDF file